The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

George Karamanolis, Stylianos Panopoulos, Konstantinos Denaxas, Anastasios Karlaftis, Alexandra Zorbala, Dimitrios Kamberoglou, Spiros D. Ladas, Petros P. Sfikakis

Arthritis Research & Therapy · 2016 · 53 citations · 15 references

DOIFull text

Open access

Abstract

ClinicalTrials.gov Identifier: NCT02363478 Registered: 21-02-2014.

References

15